ASH 2015 Conference Review - reviewed by Prof Jeff Szer

In this Review:

Efficacy of eltrombopag in severe aplastic anaemia
Venetoclax monotherapy in ultra-high risk refractory CLL
High or reduced intensity conditioning before SCT in MDS or AML?
SCT from HLA identical siblings in sickle cell disease
Midostaurin prolongs survival in newly diagnosed AML with FLT mutations
Is autologous SCT still the standard of care in multiple myeloma?
Long-term outcomes with blinatumomab in MRD+ B-cell precursor ALL
Impact of donor age on unrelated bone marrow transplantation
Clofarabine for newly-diagnosed AML in older adults

Please login below to download this issue (PDF)